Abstract
Cell lines are immortal cultures of cells that are used in research as well as for production of pharmaceuticals. Currently available cell lines are derived from normal and tumorous tissue of humans and diverse animal species, however, with considerable loss of specific properties. The development of new immortalization protocols has led to a significant improvement of the properties of the resulting cell lines. These retain specific properties and activities that include functional grafting.
Similar content being viewed by others
Literatur
Bodnar AG, Ouellette M, Frolkis M et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352
Simonsen JL, Rosada C, Serakinci N et al. (2002) Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20:592–596
Yang J, Nagavarapu U, Relloma K et al. (2001) Telomerized human microvasculature is functional in vivo. Nat Biotechnol 19:219–224
May T, Butueva M, Bantner S et al. (2010) Synthetic gene regulation circuits for control of cell expansion. Tissue Eng Part A 16:441–452
Noguchi H, Kobayashi N, Westerman KA et al. (2002) Controlled expansion of human endothelial cell populations by Cre-loxP-based reversible immortalization. Hum Gene Ther 13:321–334
Rybkin II, Markham DW, Yan Z et al. (2003) Conditional expression of SV40 T-antigen in mouse cardiomyocytes facilitates an inducible switch from proliferation to differentiation. J Biol Chem 278:15927–15934
Westerman KA, Leboulch P (1996) Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci USA 93:8971–8976
Botezatu L, Sievers S, Gama-Norton L et al. (2011) Genetic aspects of cell line development from a synthetic biology perspective. Adv Biochem Eng Biotechnol 127:251–284
May T, Eccleston L, Herrmann S et al. (2008) Bimodal and hysteretic expression in mammalian cells from a synthetic gene circuit. PLoS ONE 3:e2372
May T, Hauser H, Wirth D (2004) Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res 32:5529–5538
Author information
Authors and Affiliations
Corresponding author
Additional information
Tobias May 1996–2001 Biochemiestudium, Universität Halle-Wittenberg. 2005 Promotion in der Gruppe von Dr. D. Wirth am Helmholtz-Zentrum für Infektionsforschung. 2005–2011 Postdoc in der Abteilung Genregulation und Differenzierung am Helmholtz-Zentrum für Infektionsforschung. Seit 2011 Mitgeschäftsführer InSCREENeX GmbH, Braunschweig.
Hansjörg Hauser 1968–1973 Studium der Lebensmitteltechnologie und Ernährungswissenschaft an der Universität Hohenheim. 1977 Promotion an der Universität Konstanz in der Gruppe von Prof. Dr. R. Knippers. 1978–1980 Postdoc mit Prof. Dr. G. Schütz am MPI für Molekulare Genetik, Berlin, und am DKFZ, Heidelberg. 1981–1985 wissenschaftlicher Angestellter an der Gesellschaft für Biotechnologische Forschung (GBF), Braunschweig. 1986–1994 Leiter der AG Genetik von Eukaryonten. Seit 1994 Leiter der Abteilung Genregulation und Differenzierung, Helmholtz-Zentrum für Infektionsforschung, Braunschweig.
Dagmar Wirth 1982–1987 Chemiestudium an der TU Braunschweig. 1991 Promotion in der Gruppe von Prof. Dr. J. Bode. 1991–1996 Postdoc in der AG Hauser der GBF in Braunschweig. 1996–1998 freiberuflich tätig in der biomedizinischen Forschung. 1999–2003 wissenschaftliche Mitarbeiterin der Medizinischen Hochschule Hannover. Seit 2004 wissenschaftliche Mitarbeiterin am Helmholtz-Zentrum für Infektionsforschung; dort seit 2007 Leiterin der AG Modellsysteme für Infektion und Immunität.
Rights and permissions
About this article
Cite this article
May, T., Hauser, H. & Wirth, D. Funktionale Zelllinien durch neue Immortalisierungsprotokolle. Biospektrum 18, 390–393 (2012). https://doi.org/10.1007/s12268-012-0199-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-012-0199-3